• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Genstar Capital acquires Bracket

Genstar Capital acquires Bracket

March 28, 2017
CenterWatch Staff

Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software and industrial technology industries, has acquired Bracket, a scientifically-driven clinical trial technology and specialty services provider, from Parthenon Capital Partners.

Bracket offers an integrated suite of complementary solutions that help pharmaceutical and biotechnology companies, as well as contract research organizations, maximize clinical data integrity and ultimately improve outcomes with clinical trials. Bracket has over 700 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

Jeff Kinell, chief executive officer of Bracket, commented, "Bracket has built a strong reputation with its customers to help them increase efficiency and outcomes of their clinical trials, with a focus on complex therapeutic areas. Our software and technology-enabled services will become ever more important as our customers increasingly adopt electronic solutions to further improve execution of clinical trials. We were impressed with Genstar's deep understanding of our mission and our value and we are excited to work with Genstar to further execute on growth investments and strategic acquisitions to expand our product capabilities, enter new therapeutic areas, and continue building on our partnerships with our customers."

David Golde, a director at Genstar who leads the firm's pharmaceutical services investing efforts, said, "Bracket is a premier technology solutions provider for pharmaceutical and biotech companies looking to improve the outcomes of their clinical trials. Bracket's comprehensive suite of products and services combined with an unparalleled scientific team have been a driving force behind the company's impressive growth. We are excited to support Jeff Kinell and his team as we share a similar desire to actively pursue growth initiatives and strategic acquisitions to provide increased value to Bracket's customers."

Jean-Pierre Conte, chairman and managing director of Genstar, said, "The addition of Bracket to our portfolio of companies reinforces our commitment to investing in high quality healthcare companies with strong growth drivers that can be further transformed by our active involvement with best in class industry leaders. We are proud and excited to help Bracket navigate its next chapter in its journey of success."

Genstar's current and previous investments in healthcare technology and services companies include ERT, ConnectiveRx, Netsmart, and PRA International.

Bracket was previously a portfolio company of Parthenon Capital Partners, a growth-oriented private equity firm dedicated to building leading companies in healthcare and financial services. 

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing